Source: Fox News
Summary
A new study found that the 2024-2025 COVID-19 vaccine was linked to a lower risk of major cardiovascular events, including heart attack, stroke, and cardiovascular death, among U.S. veterans. The vaccine was found to be 37.7% effective in preventing COVID-associated major adverse cardiovascular events (MACE). The benefit was greatest among adults ages 75 and older and those with underlying health conditions. The study was observational and could not prove cause and effect, but highlighted an association between the vaccine and lower cardiovascular risk.
Our Reading
The advice sounds familiar.
The COVID-19 vaccine has been linked to various benefits and risks, with studies constantly updating and refining our understanding of its effects. This latest study adds to the growing body of evidence on the vaccine’s cardiovascular benefits. The finding that the vaccine is 50.7% effective in preventing COVID-associated MACE in people over 75 is particularly noteworthy. Dr. Glenn Hirsch, a cardiologist, notes that the result is consistent with previous studies and highlights the importance of discussing vaccination with healthcare teams annually.
The COVID-19 vaccine’s impact on cardiovascular events is a topic of ongoing research, with studies exploring its effects on heart attack, stroke, and cardiovascular death. As new variants of the virus emerge and immunity from prior infections evolves, the vaccine’s benefits may continue to shift.
One thing is certain: the COVID-19 vaccine has entered another phase of its complex and multifaceted story.
And so, the guidance on COVID-19 vaccination continues to evolve, with each new study adding another layer to our understanding of its effects.
It’s a reminder that health guidance is a work in progress, and what we know today may change tomorrow.
Author: Evan Null
